- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03694717
Time Course Evolution of Cardiac Output (TCCO)
Time Course Evolution of Cardiac Output in Critically Ill Patients After a Fluid Expansion
Fluid expansion is the first therapeutic option in patients presenting acute circulatory failure but the duration of its hemodynamic effects (persistency and time of maximal increase in cardiac output) is unknown.
This study is seeking to describe in critically ill patients, the time course evolution of cardiac output over a 2-hours period after a fluid expansion.
The objectives are:
- to identify patterns of fluid responsiveness
- to determine the time when the maximal increase in cardiac output occurs during and a after fluid expansion
- to compare patients' characteristics between patterns
Patients with acute circulatory failure will be recruited as soon as a fluid expansion will be decided by the physician in charge and the effects of fluid expansion on hemodynamic indices (cardiac output, arterial pressure) will be continuously recorded through a transpulmonary thermodilution device over a 2-hours period.
No changes in ventilatory settings nor vasopressors or sedatives will be allowed during the study.
Patients will be categorized into patterns according to the changes in cardiac output after fluid expansion and their characteristics will be compared.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The study will be conducted in four medico-surgical ICUs in France between April 2016 and April 2018.
Since fluid challenge and invasive monitoring by thermodilution device is standard of care for septic shock management, the institutional review board waived patient consent. All patients and/or their next of kind will receive written information.
Eligible patients will have to present an acute circulatory failure for whom the physician in charge will decide to start a fluid expansion.
Hemodynamic variables will be obtained through transpulmonary thermodilution and pulse contour analysis (PICCO2 device, Pulsion Germany).
Fluid expansion will consist in the infusion of 500 ml of saline through a central venous catheter in a standardized 10-minutes period. The duration of infusion will be controlled by an airbag pressurized at 300 mmHg.
Fluid responsiveness will be defined by an increase in cardiac output over 15-per-cent from baseline (before fluid expansion).
Study design:
At time of decision to make the fluid expansion, a calibration of the PICCO2 device will be performed and a first set of hemodynamic measurements will be collected (cardiac output, cardiac function index, extravascular lung water, permeability vascular pulmonary index, global end diastolic volume, arterial pressure, heart rate).
Then, fluid expansion will be administrated in less than 10 minutes. From the start of fluid expansion to the end of the two-hours period ot time, pulse contour cardiac output and arterial pressure will be continuously recorded.
During the whole two hours period, no change in vasopressor dosage nor mechanical ventilation settings will be allowed.
In case of hemodynamic instability, defined by a mean arterial pressure under 65mmHg, a new fluid expansion could be realized. In this last case, the protocol will start again from the beginning.
Studietyp
Inskrivning (Faktisk)
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- acute circulatory failure (infusion of norepinephrine)
- invasive mechanical ventilation through an endotracheal tube
- decision of fluid expansion
Non inclusion Criteria:
- extracorporeal membranous oxygenation (ECMO)
- active bleeding
- continuous renal replacement therapy with weight loss
- administration of diuretics within the past six hours
- decision of therapeutic limitation,
- age under eighteen years
Exclusion criteria:
- hemodynamic instability after fluid expansion (mean arterial pressure < 65mmHg)
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: Kohort
- Tidsperspektiv: Blivande
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
---|---|
Patients
The patients will receive a 500 ml fluid expansion over a standardized 10 minutes period
|
The fluid expansion will consist in a less than 10 min infusion of 500 milliliters of saline through a central venous catheter (jugular).
The duration of infusion will be controlled by an airbag pressurized at 300 mmHg.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Change in cardiac output during fluid expansion
Tidsram: 10 minutes
|
Difference between maximal cardiac output during fluid expansion and baseline
|
10 minutes
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Change in cardiac output after fluid expansion
Tidsram: 2 hours
|
Change in cardiac output after fluid expansion
|
2 hours
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Martin Dres, MD, PhD, APHP
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- ADOREPS
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Saline Solution for Injection
-
10xBio, LLCAktiv, inte rekryterandeEn säkerhets- och tolerabilitetsstudie av 10XB-101-injektion hos vuxna patienter med submentalt fettSubmentalt fettFörenta staterna
-
Tongji HospitalAvslutadHypotoni under operationKina
-
Seoul National University HospitalSeoul St. Mary's Hospital; Seoul National University Bundang Hospital; Gachon... och andra samarbetspartnersAvslutadNjurinsufficiens, kronisk | Akut njurskada | KontrastmediareaktionKorea, Republiken av
-
B. Braun Medical Inc.AvslutadInfektionerFörenta staterna
-
Peking University First HospitalAvslutadPostoperativa komplikationerKina
-
Acrotech Biopharma Inc.AvslutadMultipelt myelomFörenta staterna
-
Indonesia UniversityOkänd
-
Fujian Cancer HospitalHar inte rekryterat ännuAvancerad solid tumör
-
Baxter Healthcare CorporationAvslutadGastroenterit | UttorkningFörenta staterna, Kanada
-
University of CalgaryRekryteringOsteo Artrit Knä | Främre korsbandsskador | Främre korsbandsruptur | Främre korsbandsrivningKanada